Voloridge Investment Management’s Verona Pharma VRNA Stock Holding History

Voloridge Investment Management’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-21,170	Closed	-$2.26M	–	1371
2025 Q3	$2.26M	Sell	21,170 -298,047	-93%	-$31.1M	0.01%	920
2025 Q2	$30.2M	Buy	+319,217	New	+$23.6M	0.11%	234

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Voloridge Investment Management's VRNA Position: Q4 2025 in Review

Voloridge Investment Management sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 21,170 shares — an estimated $2.26M sold.

Voloridge Investment Management first reported a position in VRNA in Q2 2025 and held it in 2 quarters. The position peaked at $30.2M in Q2 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Voloridge Investment Management reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Voloridge Investment Management sold 21,170 Verona Pharma shares in Q4 2025, an estimated $2.26M.
Voloridge Investment Management first reported a position in Verona Pharma in Q2 2025 and held it in 2 quarters.
Voloridge Investment Management's Verona Pharma position peaked at $30.2M in Q2 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Voloridge Investment Management's 13F filing for Q4 2025, filed 17 Feb 2026.